Third Circuit Shows No Love For Lovenox® Bundling Theory
By Ankur Kapoor
Citing the well-known maxim that the antitrust laws are concerned with “the protection of competition, not competitors,” the U.S. Court of Appeals for the Third Circuit on Wednesday affirmed summary judgment
for Defendant Sanofi Aventis on Plaintiff Eisai, Inc.’s claim that Sanofi foreclosed competition
in the market for anticoagulant drugs administered in hospitals.
Eisai alleged that...